There is now considerable evidence that nitric oxide is an important neuroregulatory agent, but there has been very little investigation of its possible role in neuroendocrine mechanisms in humans. We have investigated the effects of two nitric oxide precursors, l-arginine and molsidomine, under basal conditions on the pituitary hormones growth hormone (GH), prolactin, luteinizing hormone, folliclestimulating hormone, thyrotrophin, adrenocorticotrophin (ACTH) and vasopressin, and also on serum cortisol; we have also studied the effect of l-arginine on circulating prolactin, ACTH and cortisol in normal human subjects under hypoglycaemic stress. l-Arginine stimulated both GH and prolactin release under basal conditions but had no effect on the other hormones studied, while the nitric oxide donor molsidomine showed no effect on any hormone studied. l-Arginine potentiated the hypogly- 
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Results
In the first study, GH release was stimulated signifi¬ cantly by L-arginine. By contrast, molsidomine had no effect on its own, and in combination with L-arginine was not different to that of L-arginine alone (Fig. 1) (Fig. 3) and vasopressin (data not shown) that was also not significantly altered by L-arginine. By contrast, the insulin-induced rise in plasma ACTH was enhanced significantly by preceding the insulin with an infusion of L-arginine (Fig. 4) 
